Chinese Researchers Develop ‘Longevity Pill’ Aiming for 150-Year Lifespan

Jakarta – A chinese startup, Lonvi Biosciences, specializing in longevity and biosciences, claims to have developed a “longevity pill” with the potential to extend human lifespans to 150 years. The pill focuses on targeting senescent cells – cells that have stopped dividing and contribute to inflammation and age-related diseases.

“This is not just another pill. The main ingredient in this new drug not only increases longevity, but also reduces age-related diseases by strengthening cellular level health,” stated lonvi CEO, Ip Zhu, according to Oddity Central.

How Does the Pill Work?

The core of Lonvi Biosciences’ approach lies in addressing cellular senescence. As we age, cells can become damaged or stressed and enter a state of senescence. These senescent cells don’t function properly and release harmful molecules that contribute to inflammation and various age-related conditions like arthritis,heart disease,and even cancer.

The “longevity pill” contains a novel compound designed to selectively eliminate these senescent cells, a process known as senolysis. By removing these dysfunctional cells, the pill aims to restore tissue function, reduce inflammation, and ultimately extend healthy lifespan. While the specific compound remains proprietary, Lonvi Biosciences suggests it represents a meaningful advancement in senolytic therapy.

Current Status and Future Outlook

The pill is currently undergoing preclinical trials, and Lonvi Biosciences plans to begin human trials in the near future. The company is optimistic about the potential of their discovery,but acknowledges that extensive research and testing are necesary to confirm its safety and efficacy.

Ip Zhu emphasized the company’s commitment to rigorous scientific validation. “We are dedicated to conducting thorough clinical trials to ensure the pill’s safety and effectiveness before making it available to the public,” he said.

Potential Implications

If successful, this “longevity pill” could revolutionize healthcare and dramatically alter our understanding of aging. Extending healthy lifespan could have profound societal implications, impacting everything from healthcare systems and retirement planning to workforce dynamics and population growth. However, ethical considerations surrounding access and equity will also need to be addressed.

Key Takeaways

• Lonvi Biosciences has developed a pill targeting senescent cells to potentially extend human lifespan to 150 years.
• The pill aims to reduce age-related diseases by eliminating dysfunctional cells and reducing inflammation.
• Human trials are planned, but the pill is currently in preclinical testing.
• Successful development could have significant societal and ethical implications.

publication Date: 2025/11/20 11:50:38